While all poly ADP-ribose polymerase (PARP) inhibitors improved progression-free survival, olaparib significantly extended overall survival (OS), making it a preferred option.

The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with opioids.

Two new compounds may be able to treat retinitis pigmentosa, a group of inherited eye diseases that cause blindness. The compounds were identified using a virtual screening approach.

Suzetrigine (Journavx) is the first new drug approved to treat acute pain in over 20 years and the first to be classified as ...

The Fraternal Order of Police of Ohio will be recognizing Columbus police officer Gloria West and Pataskala police officer ...

ANDECAL study, a Phase 2/3 clinical trial evaluating the safety, efficacy, pharmacokinetics (PK), and pharmacodynamics (PD) of andecaliximab in patients with fibrodysplasia ossificans progressiva (FOP ...

Treatment for allergic or irritant contact dermatitis may include home remedies such as cool compresses, moisturizers, and lukewarm baths. You may also require over-the-counter and prescription ...

For Botox treatment, you'll usually get around 30 small injections into key areas around your face, head, and neck. You usually need to repeat this treatment every 10-12 weeks. And it may take six ...

Bone loss resulting from trauma, fractures, or disease presents a major global health challenge, often leading to long-term disability.

Effective treatments for people with serious depression who have not been helped by antidepressant medications have novel ...

In a mouse model of fibrodysplasia ossificans progressiva (FOP)—a genetic condition causing ... pathology, diseases and treatment. The authors declare that they have no competing interests.